Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 191 | 328 | 330 | 257 | 412 |
| Cost of Goods | 92 | 174 | 176 | 153 | 214 |
| Gross Profit | 99 | 154 | 154 | 104 | 198 |
| Operating Expenses | 3,090 | 2,233 | 1,742 | 2,135 | 2,172 |
| Operating Income | -2,899 | -1,905 | -1,412 | -1,878 | -1,760 |
| Other Income | 1,078 | 306 | 215 | 49 | 43 |
| Pre-tax Income | -1,821 | -1,599 | -1,197 | -1,829 | -1,717 |
| Net Income Continuous | -1,821 | -1,599 | -1,197 | -1,829 | -1,717 |
| Net Income | $-1,821 | $-1,599 | $-1,197 | $-1,829 | $-1,717 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.01 | -0.02 | -0.02 |
| EBITDA(a) | $-2,780 | $-1,764 | $-1,258 | $-1,721 | $-1,615 |